Cargando…

Differential Use of Radiotherapy Fractionation Regimens in Prostate Cancer

IMPORTANCE: Technical advances in treatment of prostate cancer and a better understanding of prostate cancer biology have allowed for hypofractionated treatment courses using a higher dose per fraction. Use of ultrahypofractionated stereotactic body radiotherapy (SBRT) has also been characterized. O...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qureshy, Sarah A., Diven, Marshall A., Ma, Xiaoyue, Marciscano, Ariel E., Hu, Jim C., McClure, Tim D., Barbieri, Christopher, Nagar, Himanshu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2023
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10565603/ https://www.ncbi.nlm.nih.gov/pubmed/37815829 http://dx.doi.org/10.1001/jamanetworkopen.2023.37165

Ejemplares similares

A randomized phase II trial of MR-guided prostate stereotactic body radiotherapy administered in 5 or 2 fractions for localized prostate cancer (FORT)
por: Wolfe, Sydney, et al.
Publicado: (2023)

Randomized phase II trial of MRI-guided salvage radiotherapy for prostate cancer in 4 weeks versus 2 weeks (SHORTER)
por: Marciscano, Ariel E., et al.
Publicado: (2023)

Trends in Diagnosis and Disparities in Initial Management of High-Risk Prostate Cancer in the US
por: Agrawal, Vishesh, et al.
Publicado: (2020)

Trends in Androgen Deprivation Use in Men With Intermediate-Risk Prostate Cancer Who Underwent Radiation Therapy
por: Agrawal, Vishesh, et al.
Publicado: (2022)

Hypofractionated Postoperative Radiotherapy for Prostate Cancer: Is the Field Ready Yet?
por: Mahase, Sean, et al.
Publicado: (2020)

Management of High-Risk Localized Prostate Cancer
por: Marciscano, Ariel E., et al.
Publicado: (2012)

Long-term results of intensity-modulated radiotherapy with three dose-fractionation regimens for localized prostate cancer
por: Takemoto, Shinya, et al.
Publicado: (2019)

A Systematic Mutational Analysis of a Histone H3 Residue in Budding Yeast Provides Insights into Chromatin Dynamics
por: Johnson, Paige, et al.
Publicado: (2015)

Quantifying the impact of SpaceOAR hydrogel on inter‐fractional rectal and bladder dose during 0.35 T MR‐guided prostate adaptive radiotherapy
por: Farjam, Reza, et al.
Publicado: (2021)

Differential effects of radiation fractionation regimens on glioblastoma
por: McKelvey, Kelly J., et al.
Publicado: (2022)

Cancer and COVID-19 — potentially deleterious effects of delaying radiotherapy
por: Nagar, Himanshu, et al.
Publicado: (2020)

Differential Regulation of Antagonistic Pleiotropy in Synthetic and Natural Populations Suggests Its Role in Adaptation
por: Yadav, Anupama, et al.
Publicado: (2015)

Population Differentiation at the PVT1 Gene Locus: Implications for Prostate Cancer
por: Pal, Gargi, et al.
Publicado: (2020)

Is there a role for an external beam boost in cervical cancer radiotherapy?(†)
por: Sethi, Rajni A., et al.
Publicado: (2013)

Association of Stress With Cognitive Function Among Older Black and White US Adults
por: Kulshreshtha, Ambar, et al.
Publicado: (2023)

Assessment of Toxic Effects Associated With Dose-Fractionated Radiotherapy Among Patients With Cancer and Comorbid Collagen Vascular Disease
por: Yoon, Stephanie M., et al.
Publicado: (2021)

Stereotactic radiotherapy of the prostate: fractionation and utilization in the United States
por: P. Weiner, Joseph, et al.
Publicado: (2017)

Long-term Outcomes of Stereotactic Body Radiotherapy for Low-Risk and Intermediate-Risk Prostate Cancer
por: Kishan, Amar U., et al.
Publicado: (2019)

Single fraction radiotherapy versus multiple fraction radiotherapy for bone metastases in prostate cancer patients: comparative effectiveness
por: Yoon, Frederick, et al.
Publicado: (2014)

Evaluation of Deep Learning to Augment Image-Guided Radiotherapy for Head and Neck and Prostate Cancers
por: Oktay, Ozan, et al.
Publicado: (2020)

Comparison of Response to Definitive Radiotherapy for Localized Prostate Cancer in Black and White Men: A Meta-analysis
por: Ma, Ting Martin, et al.
Publicado: (2021)

Comparison of Online-Onboard Adaptive Intensity-Modulated Radiation Therapy or Volumetric-Modulated Arc Radiotherapy With Image-Guided Radiotherapy for Patients With Gynecologic Tumors in Dependence on Fractionation and the Planning Target Volume Margin
por: Guberina, Maja, et al.
Publicado: (2023)

Individual and Population Comparisons of Surgery and Radiotherapy Outcomes in Prostate Cancer Using Bayesian Multistate Models
por: Beesley, Lauren J., et al.
Publicado: (2019)

Deep learning‐based synthetic CT generation for MR‐only radiotherapy of prostate cancer patients with 0.35T MRI linear accelerator
por: Farjam, Reza, et al.
Publicado: (2021)

Complexity of Medication Regimens for Children With Neurological Impairment
por: Feinstein, James A., et al.
Publicado: (2021)

Avelumab demonstrates promise in advanced NSCLC
por: Marciscano, Ariel E., et al.
Publicado: (2017)

Development and Validation of a Multi-institutional Nomogram of Outcomes for PSMA-PET–Based Salvage Radiotherapy for Recurrent Prostate Cancer
por: Zamboglou, Constantinos, et al.
Publicado: (2023)

Evaluating Post-Radiotherapy Laryngeal Function with Laryngeal Videostroboscopy in Early Stage Glottic Cancer
por: Marciscano, Ariel E., et al.
Publicado: (2017)

Association of the Placement of a Perirectal Hydrogel Spacer With the Clinical Outcomes of Men Receiving Radiotherapy for Prostate Cancer: A Systematic Review and Meta-analysis
por: Miller, Larry E., et al.
Publicado: (2020)

Assessment of the Safety of Glucocorticoid Regimens in Combination With Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer: A Randomized, Open-label Phase 2 Study
por: Attard, Gerhardt, et al.
Publicado: (2019)

Association of Bone Metastatic Burden With Survival Benefit From Prostate Radiotherapy in Patients With Newly Diagnosed Metastatic Prostate Cancer: A Secondary Analysis of a Randomized Clinical Trial
por: Ali, Adnan, et al.
Publicado: (2021)

Assessment of Second Primary Cancer Risk Among Men Receiving Primary Radiotherapy vs Surgery for the Treatment of Prostate Cancer
por: Bagshaw, Hilary P., et al.
Publicado: (2022)

Intra-fraction displacement of the prostate bed during post-prostatectomy radiotherapy
por: Bell, Linda J., et al.
Publicado: (2021)

Magnetic Resonance Imaging–Guided vs Computed Tomography–Guided Stereotactic Body Radiotherapy for Prostate Cancer: The MIRAGE Randomized Clinical Trial
por: Kishan, Amar U., et al.
Publicado: (2023)

Fractionation, Stability, and Isolate-Specificity of QTL for Resistance to Phytophthora infestans in Cultivated Tomato (Solanum lycopersicum)
por: Johnson, Emily B., et al.
Publicado: (2012)

Prostate cancer grade migration and facility-level treatment trends for grade group 1 disease
por: Borregales, Leonardo D, et al.
Publicado: (2023)

Role of noninvasive molecular imaging in determining response
por: Marciscano, Ariel E., et al.
Publicado: (2018)

Use of focal radiotherapy boost for prostate cancer: radiation oncologists’ perspectives and perceived barriers to implementation
por: Zhong, Allison Y., et al.
Publicado: (2023)

Opioid Dose Trajectories and Associations With Mortality, Opioid Use Disorder, Continued Opioid Therapy, and Health Plan Disenrollment
por: Binswanger, Ingrid A., et al.
Publicado: (2022)

Single vs. multiple fraction regimens for palliative radiotherapy treatment of multiple myeloma: A prospective randomised study
por: Rudzianskiene, Milda, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_cvr15tglgpm91pfa51tfjk49cf